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ABSTRACT
A study has been made of the utilization of laboratory testing in
a major teaching hospital. Two measures of laboratory utilization were
considered: 1) the total number of tests performed in the chemistry
laboratory over the past ten years and 2) tests used in the management
of a group of patients with a diagnosis of uncomplicated acute myocardial
infarction over a period of fifteen years. In each case, test volume
data was compared with technological, environmental and cultural change
within the hospital and laboratory. Both groups of data showed an
approximately exponential growth in chemistry test utilization over the
past decade. Over 90% of the total test volume in each year comprised
a group of 23 tests. Although there was a dramatic increase in the num-
ber of different tests utilized, from 100 to over 600, during the period
studied, new tests contributed little to the increase in test volume.
Significant changes in laboratory technology occurred during the period
studied, in particular the introduction of automated and multichannel
analyzers. There was evidence that these technological changes caused
a small increase in laboratory test growth rate, but the effect was pre-
dominantly in the facilitation of increased demand. Clear evidence was
obtained of a change in physician behavior; there was a marked reduction
in the average interval between tests and a greater tendency to use tests
for monitoring as opposed to diagnosis in more recent years.
Name and Title of Thesis Supervisor: Edward B. Roberts, David Sarnoff
Professor of the Management of Technology
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Chapter I INTRODUCTION
1.1 The Cost of Health Care
care expenditure the United States has in-
creased exponentially from $4 billion in 1940 to
in 1975. The increase in Gross Na
same interval has been from $100 b
Thus the fraction of GNP spent on
creasing, as shown in Table 1.1.
increase has been a technological an
medicine which has taken place in
Increased costs were justified bec
placed on health, and even life it
as health care costs continue to r
between medical care and other des
(1). As a result, in recent years
benefits of health ca
and are a major publi
most other industrial
Health care con
total expenditures on
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illion to $1
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the costs a
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ized nations.
sumers annually sp
pharmaceuticals,
the remaining 75% is
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$118 billion
during the
billion.
been in-
f this cost
volution in
decades.
y high value
parent that
st be made
d services
resulting
tical examina
United States
end about 25%
medical suppl
t ion
and
their
and
spent on wages, fees and
other non-product items as shown in Figure 1.1 (2). Hospital
care and physicians services are the two largest sectors of
health care costs and together account for almost two thirds
Health
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TABLE 1. I1
HEALTH CARE EXPENDITURE AS A FRACTION OF GNP
Health Care Expenditure
$ billions
3.86
12.03
25.86
38.89
42.11
47.88
53.77
60.62
69.20
77.16
86.69
95.38
104.03
118.50
Fraction of GNP
3.87
4.22
5.13
5.69
5.61
6.03
6.22
6.52
7.08
7.31
7.49
7.37
7.36
7.82
Source: Social Securi
Year
1940
1950
1960
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
ty Administration
FIGURE 1.2
Product Analysis of Health Care Expenditures, 1975
(Consumer Expenditures)
Sectoral Analysis of Health Care Expenditures, 1975
Billion $$10.0
3.5
2.5
2. 25%
1.2
0.9
9.0
Dental Car
$ 7.5 Billic
Medicine
$ 10.6 Bil
Total: $ 117.6 Billion
Source: Arthur D. Little, Inc. estimates
Source: Division of Health Insurance Studies, Social
Security Administration
FIGURE 1.1
of total expenditures
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(Figure 1.2). Not unexpectedly, hospital
services have shown the fastest rising costs in the health
care are
hospital
policy (
creasing
The cost
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y expect and receive
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the course of their
physicians who care
rapid growth
U.S. health
reflects the
care provid
among the 1
osts. Patie
a battery o
o used to mo
hospital st
for them hav
been satisfied with less than technical excellence in
medical care.
1.2 Laboratory Medicine
The practice of medicine has changed substantially dur-
ing this century, largely as a result of diverse and contin-
uing technological innovation (4). It can be argued that
physicians' ability to alter the outcome of the disease was
almost non-existent until the development of twentieth
century pharmaceuticals. Successful application of these
powerful therapeutic agents is dependent on accurate diagnosis
which is increasingly achieved through sophisticated tech-
nological means.
Diagnostic laboratory methods used in modern medicine
of
care
in-
ed.
ead-
nts
f
ni-
ay.
e
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(a) visualization: endoscopy, x-ray, nuclear and
ultrasonic imagin
ary function, EKG
ogy, microbiology
medicine can be c
2) increasing use
not surprising th
benefit analysis
interest is focus
studies have been
There are a
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1.3 The Clinical
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medicine (5)
nical laborat
other areas,
15,000 clinic
hysicians' of
of technology,
is, therefore,
in the cost/
uch of this
although
. x-ray (6).
aboratories in
laboratories
f of the total are hospital laboratories,
er are independent.
L aboratory
medicine has participated in a major way in
revolution. Significant innovations have
branch of medicine from a relatively prim-
dustry" into a highly sophisticated, highly
of impressive analytical capacity, capable
ytical data at a very rapid rate and quan-
innovations that have brought about this
transformation are the following (9):
(1) The introduction of quality control procedures in-
to the clinical laboratories in the 1950s providing the essen-
include:
o0
a
f
l
f
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tial element of reliability and confidence in results (10).
(2)The
in the early
volumes of re
manpower (11)
(3)The
itating the i
from the clini
introduction
1960s permit
latively rel
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roduction
rnal hand
laborato
1.3.1-Clinical Laborat
These technolog
clinical laboratories
clinical demands for
remarkable increase i
over the past 20 year
the period 1970-1975,
increased at an annua
(7,8); clinical chemi
atory tests. Figures
laboratory growth pat
tests were performed
1971 and reached over
accelerating rate of
teaching hospital of
volume from 1963-1976
ory
of multichannel automatic
ted the rapid generation of
iable data with minimal tec
of electronic data process
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ry to the clinicians.
Development
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opments have permitted the
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ing to national surveys, for
r of clinical laboratory tests
13.8% in hospital laboratories
prise about 30% of all labor-
and and Wales indicate similar
1961, 21 million laboratory
figure rose to 46 million in
n by 1976, showing again an
aboratory utilization at the
sity of Minnesota tripled in
little change in the number of
patients or other patient-related factors. In another study
from the teach
1971, Griner (
ly 40% of all
bill; between
atory tests in
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ng hospital of the University of Rochester in
2) found chemistries accounted for approximate-
aboratory charges and 10% of the total hospital
965 and 1970, the number of chemistry labor-
reased by 95%.
The overall incr
variability in growth
However, studies of se
have also demonstrated
utilization. A study
cardial infarction bet
increased chemistry te
cal examinations witho
of hospitalization or
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utilization by diffe
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a teaching hospital
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costs in 1975 was due to increased
increase in the cost of services i
probably reflects increased effici
related to automation.
1.4 Factors Contributing to Increa
Testing
These factors may be divided
unit costs.
s remarkably
ency of the
This 6.5%
low, and
laboratories
sed Clinical Chemistry
into three major categor-
ies:
Laboratory factors
Patient factors
Physician factors
I. Laboratory factors:
(a) Increased capability and reliability of results,
with development of automated multichannel analysis.
(b) Advances in medical knowledge, particularly in the
discovery of new relationships between biochemical alterations
and disease. There has been a remarkable increase in avail-
able laboratory tests from 100 tests in 1950 to more than 600
at present. One contributing factor is that old technology
is replaced but not completely retired, resulting in an
increased test pool size.
(c) Perceived need to keep up with the latest technol-
ogy, in part necessitated by the increased demands on the
laboratories by the clinicians.
2. Patient factors:
(a) The method of payment has changed, with increase in
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third party payments for health care
ance carriers, Medicare and Medicaid
ance coverage. These are associated
pocket expenses, particularly as a
ability as a fringe benefit as well
health insurance costs from income
(b) Local factors such as "ca
pital. The introduction of increas
and sophisticated services, such as
also stimulated laboratory utilizat
3. Physician factors:
(a) The type and location of
has a major influence on laboratory
cians are trained in university tea
tend to utilize the laboratories to
community hospitals (16), and which
ical research into the introduction
laboratory tests. Furthermore thei
ialists who, as a group, tend to us
greater extent; physicians who were
through private insur-
providing broader insur-
with decreased out-of-
consequence of their avail -
as the deductibility of
taxes.
se mix" and type of hos-
ingly complex technology
intensive care units has
ion.
training of the physicians
utilization. Most physi-
ching hospitals, which
a greater extent than
are the location of clin-
and evaluation of new
r role-models are spec-
e laboratories to a
found to be high users
tended to be members of groups in which the leadership exhib-
ited this characteristic.
(b) Pressure by superiors and peers on house officers
to do comprehensive work-ups and avoid missing diagnosis,and
to avoid failure to monitor and detect changes in the
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patient's condition.
(c) The type of practice also has
increasing specialization, the attending
less comfortable with medical problems ou
of expertise and are more reluctant to cr
strain laboratory usage by house officers
unfamiliar areas.
(d)
response
sequent i
less sign
clinical
an influence. With
physicians become
tside of their area
iticize and con-
in these relatively
Increase in the practice of defensive medicine, in
to increased threat of malpractice suits. The con-
ncreased tendency to order additional tests is much
ificant in the clinical laboratory areas such as
chemistry, than in radiology.
The increased emphasis on
concept of frequent, regu
lthy individual, including
in which chemistry testing
preventative medicine has
ar systematic evaluation
multiphasic laboratory
plays a significant role.
(f) Relatively inadequate physician education in
clinical laboratory medicine, giving rise to an insufficient
awareness of particular test characteristics such as reli-
ability, or the diagnostic implications of various levels of
test sensitivity and specificity.
(g)
hospitals.
The initiation of quality assurance programs in
These seek to establish minimal standards of care
(e)
the
hea
ing
led to
of the
screen
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for various diseases, and monitor
standards. In quantitative terms
significant factor in recent incr
tory utilization, since they are
standards of laboratory usage rat
excess utilization.
1.5 Objectives
The objective
depth the increase
teaching hospital.
excellence and serv
factors contributin
e
g
conformance with these
these programs are not a
eases in clinical labora-
concerned with minimal
her than the issue of
of the present study was to examine in
n laboratory utilization in a university
This hospital has a reputation for
s as a model for the examination of
to increasing laboratory test volumes.
The approach we have taken is to examine both the
laboratory as a whole and as utilized in a well-defined
group of patients having a common principal diagnosis. In
each case we have reviewed the changes in laboratory testing
over an extended period, ten years for the laboratory as a
whole, and fifteen years for the patient group. In addition,
technological, environmental and cultural changes within the
hospital have been documented where possible. This set of
data allows us to evaluate the relative importance of factors
affecting the utilization of laboratory tests.
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Chapter 2 METHODOLOGY
2.1 The Hospital
The hospital is
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Much of the daily activity at the hospital is tied
the health-related research vital to the continued growt
medical knowledge and improved patient care. Supported
largely by government agencies and private foundations a
organizations, over 300 research programs budgeted at $8
million are conducted annually.
During the period of the current study, one major
hospital building was completed in 1973, adding approxim
96 adult beds, including a four-bed coronary care unit (
which became operational in March 1973.
2.2 Study of Total Clinical Chemistry Laboratory Testing
F1969-1978)
The data on the numb
ical chemistry laboratory
print-outs which enumerate
formed during that period.
initiated in 1972, so that
through this source. Aggre
chemistry tests beginning
hospital source; these fig
ward corresponded very wel
computer print-outs. The
major tests was determined
ers of tests performed by the clin-
was obtained from monthly computer
d the frequency of all tests per-
This computer program was first
earlier data was not available
gate data on the total number of
in 1969 was available from another
ures for total tests from 1972 on-
1 with figures obtained from the
monthly frequency of each of 23
for the period 1972-1978. These
constitute over 90% of
linical chemistry labora
Data on admissions, tota
the total
tory.
1 patient
testing performed by
days and length of
to
h of
nd
new
ately
CCU),
tests
the c
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stay were obtained from summary monthly reports of hospital
activity.
The interpretation
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which
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during this period.
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,rtion of the study was to compare
chemistry laboratory testing, in
ts, during the last 15 years. We
farction because these patients
ial volume of laboratory testing,
reasingly sophisticated and spec-
uncomplicated myocardial infarc-
tion were selected from among a larger group of patients with
0 0
TABLE 2.1
THE DISTRIBUTION OF PATIENT DAYS ACCORDING TO CLINICAL AREAS
DEPARTMENT 1970-71
ADULT
Medicine 31,430
Surgery
Thoracic Surgery 715,627
Dental
Otolaryngology 1,349
Gynecology 5,738
Urology 3,622
Orthopedics 7,488
Neurosurgery 2,241
Neurology 3,137
Opthalmology 414
Adult Total 72,046
PEDIATRIC
Medicine -13667
Psychiatr 13667
Infectious Disease 283
Surgery5,0
Thoracic Sur ger 5,204
Otolaryngology 536
Dental 168
Urology 2,194
Orthopedics 2,920
Neurosurgery 2,098
Neurology 1,057
Ophthalmology 226
Pediatric Total 28,353
1971-72 1972-73 1973-74 1974-75 1975-76 1976-77 1977-78
29,168 33,021 35,842 35,048
15,939
15,037 17,086 19,278 3,207
532
1,703 1,729 2,089 1,999
5,893 6,880 7,473 7,469
3,167 3,291 2,576 2,714
8,606 7,913 9,757 12,211
2,924 4,415 4,461 4,669
4,171 4,288 5,299 5,038
362 507 431 447
71,031 79,130 87,206 89,273
14,229
4,743
427
165
1,949
3,341
1,389
1,059
228
27,530
13,536
2,086
4,348
386
164
1,899
3,726
1,582
1,063
257
29,047
14,752
3,039
4,391
441
180
2,186
4,385
1,072
937
230
31,613
14,818
832
3,131
3,300
1,338
421
146
2,164
4,633
940
870
243
32,836
38,305
19,676
3,674
586
1,547
7,963
3,188
11,918
5,777
4,913
469
98,016
15,426
767
2,813
3,104
1 ,282
469
80
2,693
4,155
1,151
700
187
32,827
34,465
21,535
4,778
491
1,797
6,825
3,127
12,413
5,668
5,063
317
96,479
15,637
1,088
2,137
3,758
1,503
389
93
1,901
4,336
898
905
226
32,871
35,361
20,328
4,625
652
2,151
6,495
2,525
11 ,446
5,774
5,184
400
94,941
14,197
1,335
2,888
4,161
1,419
335
105
274
4,863
978
2,034
164
32,753
that discharge diagnosis.
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For the period 1963 through 1968
the study group was finally selected
myocardial infarcts by direct review
Starting in 1970, the discharge diagn
International Classification of Disea
stored in a computer program, so that
patients with the discharge diagnosis
infarction could be obtained. From t
uncomplicated acute myocardial infarc
their hospital charts were reviewed.
cardiac arrythmias, congestive heart
cations were selected for further ana
from among those with
of hospital charts.
oses (in the form of
se Adapted 
-ICDA-8) were
a print-out of all
of acute myocardial
hese data, cases with
ts were selected and
Only cases without
failure or other compli-
lysis of laboratory
utilization.
For each
ined and all c
on a daily bas
ting all chem
hospital day.
2.3. The freq
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of the normal
cated with an
patient studied,
linical chemistry
is. This yielded
istry tests for t
Examples are ill
uency of abnormal
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limits set by the
asterisk [*] desi
the hospi
determina
tal
tion
record
s were
w
t
a comprehensive chart
he admission according
ustrated on Tables 2.2
tests were also recor
al if the values fell
laboratory. (These ar
gnation in the example
as exam-
abulated
tabula-
to
and
ded;
outside
e indi-
s.)
Tables 2.4a and b compare some of the general features
of the patients in the study.
and the frequency of males to
icantly throughout the study.
The
fema
The
average age of the pat
les did not change sign
re was a gradual reduct
ents
f-
on
TABLE 2 .2
TEST 8/ --
TEST 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
SMA-6 - 1 (6 tests)
Sodium +
Potassium +
Chloride +
CO2  +
BUN +
Creatinine +
Glucose +, + +
Bloodgases (3 tests)
Enzymes (4 tests)
SGOT +' +- + + +
SGPT
LDH +, +, +' +9 +
CPK
Isoenzymes
LDH
CPK
SMA-6 - II (6 tests)
Calcium
Phosphate
Total protein
Albumin
Bilirubin
Cholesterol
Alkaline phosphatase +
Others
Digoxin
Pronestyl
TOTAL 4 3---3 - 2 1 - - - - 6 - 1 - -
Patient: G,M.
Age: 79
Hospital #158-110
Dates of
Hospitalization:
8/7/63 - 8/25/63
19 Days
Total Tests - 20
+ Test(s) reported
* Abnormal result
- 22 -
TABLE 2.3
,Patient: A,E. Age 60
Hospital #99 87 39
Dates of Hospitalization:
2/16/77 - 3/2/77 - 15 days
Total tests - 118
TEST 2/ 3/
16 17 18 19 20 21 22 23 24 25 26 27 28 1 2
SMA-6 - I (6 tests) + + + + + + +
Sodium + + + + + +
Potassium + + + + + + + +
Chloride + + +, +* , +,
C02 + +, + + + +
BUN 
-
Creatinine , 
-,
Glucose + +
Bloodgases (3 tests)
Enzymes (4 tests)
SGOT ++ +* +*
SGPT ++ + +
LDH ++ +, +,
CPK ++ +, +,
Isoenzymes
LDH
CPK ++ +, +,
SMA-6 - II (6 tests) + +
Calcium
Phosphate
Total protein
Albumin
Bilirubin
Cholesterol
Alkaline phosphatase +
Others
Uric Acid +. +- + + , , +, +
Amylase + +
T5 Uptake +
T4  +
Free T4 +
TOTAL 27 23 12 6 4 1 4 6 7 5 5 5 6 5
- 23 -
TABLE 2.4a
YEAR NAME SEX AGE (years) LENGTH OF TOTAL
STAY TESTS
1963 C,R. M 54 15 days 12
C,A. M 48 16 " 26
D,M. F 56 17 23
F,A. F 72 27 67
G,A. F 69 24 " 95
G,B. M 63 19 52
G,M. F 79 19 20
L,F. F 70 23 53
M,F. F 62 21 " 32
M,D. M 68 33 " 71
S,R. M 62 21 " 37
P,J. F 52 22 " 19
W,A. F 45 22 " 28
Y,J. M 69 29 " 23
Average 62 yrs. 22 days 30
1967 H,H. M 59 19 days 63
M,J. M 73 18 " 41
M,F. M 41 17 " 36
Average 58 yrs. 18 days 47
1968 B,V. M 58 15 days 47
F,A. F 72 27 67
G,J. M 59 21 64
G,J. M 57 23 " 60
H,J. M 60 22 34
L,J. M 68 25 67
M,E. F 55 19 41
S,A. F 61 23 " 32
Z,L. M 76 24 56
Average 63 yrs. 22 days 52
1970 B,F. M 49 25 days 74
C,N. M 50 19 32
F,F. M 81 20 54
M,A. F 68 28 52
P,S. M 40 23 " 61
S,G. F 72 18 " 43
V,C. F 60 16 " 55
Average 60 yrs. 21 days
- 24 -
TABLE 2.4b
YEAR NAME SEX AGE (years) LENGTH OF TOTAL
STAY TESTS
1973 B,F. F 80 15 days 39
F,J. M 64 11 " 24
G.E. F 70 16 90
G,E. M 54 15 106
H,H. F 67 21 59
L,M. M 75 15 66
L,G. M 65 25 95
N,M. M 64 16 " 121
R,M. M 71 16 51
S,H. M 72 24 106
W,A. F 66 12 76
Average 62 yrs. 17 days 75
1975 B,H. M 68 14 days 76
D,L. M 73 21 " 87
G,E. F 76 15 " 101
G,R. F 78 14 " 75
K,B. F 92 18 " 92
P,C. M 55 21 " 88
Average 74 yrs. 17 days 87
1977 A,E. F 60 15 days 118
F,H. F 60 19 179
F,R. M 55 16 286
L,G. M 69 18 143
M,F. M 58 19 80
P,S. M 59 22 160
S,K. M 34 12 69
W,H. M 70 17 " 84
Average 59 yrs. 17 days 139
1978 A,L. M 63 17 days 165
E,A. M 75 20 179
G,E. M 58 10 85
M,M. F 61 15 " 139
M,R. M 70 17 207
M,M. F 62 13 245
Average 6 5 yrs. 15 days 170
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Na 4 MANUAL
K' # MANUAL
Cl02 AA
CO2  A AA
DBlkl - AA
CREAT 4 AA-
Glucose-' AA
TP -4 MAN -P- -
Alb. --o MAN 0 4
Ca 4 MAN -I--
P04 -- MAN -M
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I . __ q -
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major enzymes (SGOT, SGPT, LDH and
utilizing the Abbott ABA-100. Alka
determined with this instrument in
The next major technological
1976 when a second Technicon SMA-6
determination of TP, Alb, Ca, P04 ,
A GEMSAEC was also introduced for a
at this time; serum cholesterol was
1977, and amylase in 1978. Finally
were determined by the technologica
CPK*) were determined
line phosphatase was
1973.
improvement occurred in
was introduced for the
uric acid and hilirhin
11 enzyme determination
determined by ABA-100
, arterial blood gases
lly superior Radiometer
ABL-2 in 1978.
A brief description of some of the main
these instruments follows:
a. AutoAnalyzer (Technicon Instruments, Inc.)
The AutoAnalyzer (AA), developed by Skeg
sents a first attempt to introduce automation
mechanization) into the clinical chemical labo
AutoAnalyzer utilized the principle of continu
pump moves the sample blood serum and necessar
along a series of plastic tubes continuously.
features of
gs (17) , rep
(or at least
ratory. The
ous flow: a
y reagents
Appropriate
re-
I
methods are used to separate serum proteins, dilute the
* SGOT is the abbreviation for serum glutamic oxaloacetic
transminase; SGPT stands for serum glutamic pyruvic trans-
minase; LDH is lactic acid dehydrogenase, and CPK is creati-
nine phosphokinase.
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FIGURE 2.1
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of up to 150 measurements per hour, about 5-20 times the rate
for equivalent manual procedures.
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.
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2.5 Environment
2.5.1.Malpractice I
As a consequence
the cost of malpractice
ably high rate in recent
changes in premium rates
classes of physicians in
While some rate increase
ticularly in higher risk
went into effect in 1972
increase through 1974.
nsurance Rate Changes
of increased malpractice
insurance has increased
years. Table 2. 6 indic
between 1965 and 1977,
Massachusetts (100/300
s began between 1968 and
classes), the major in
and continued at this h
Further increases contin
litigation,
at a remark-
ates the
for five
limits).
1972 (par-
creases
igh rate of
ued up to
TABLE 2.6
MALPRACTICE COSTS
PHYSICIANS & SURGEONS RATES 100/300 LIMITS
CLASS
C
$ 208.00
272.00
284.00
357.00
522.00
794.00
1,092.00
1,529.00
1,757.00
2,081.00
2,556.00
* Rates - 25/75 Limits
YEAR
1965
1966
1968
1969
1972*
1972
1973
1974
1975
1976
1977
A
$ 87.00
103.00
95.00
119.00
138.00
209.00
288.00
403.00
469.00
548.00
552.00
B
$109.00
130.00
167.00
210.00
242.00
368.00
506.00
708.00
824.00
,250.00
,425.00
D
$ 276.00
408.00
396.00
497.00
726.00
1,104.00
1,518.00
2,125.00
2,447.00
3,010.00
3,644.00
E
---
494.00
622.00
907.00
1,380.00
1,898.00o
2,657.00
3,060.00
3,810.00
4,158.00
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the present, but not at the approximately 30% rate of
increase seen in 1972-1974.
Chapter 3.
3.1 Total Tests
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TOTAL CHEMISTRY LABORATORY UTILIZATION
Performed
Durin
performed p
creased fro
volumes for
trend curve
test volume
rate slowed
recurred in
Table 3.1 s
year and as
volume with
g the period 1969-78, the total num
er year in the analyzed chemistry 1
m 270 thousand to over 930 thousand
intermediate years are shown in Ta
for test volumes is shown in Figur
s grew exponentially from 1969 unti
briefly in 1975, but the increased
1976 and 1977, moderating somewhat
hows the growth in tests as a % ove
an absolute rate (first derivative
respect to time). It may be noted
ber of tests
aboratory in-
. Total test
ble 3.1 and a
e 3.1. Total
1 1974. The
growth rate
in 1978.
r the previous
of total test
that the growth
rate is slightly higher during the period 1972-74 than during
1975-77.
Changes in total laboratory utilization may reflect
changes in the utilization of the hospital in its entirety,
as well as utilization of chemistry tests in patient care.
We, therefore, calculated the average number of tests per
hospital admission and per patient day of admission for
each year during the period 1969 to 1978. These results are
compared with the total number of tests per year in Figure
3.2 and Table 3.2. The general shape of the curves showing
tests per day and tests per admission is very similar to
that of the total tests. We conclude that hospital
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TABLE 3. 1
GROWTH IN TOTAL CHEMISTRY TESTS
Total
Tests
(thousands)
268.9
272.3
309.5
442.80
588.20
639.00
755.70
892.30
934.77
% Increase
Over prior year
1
13
38
33
9
18.2
18
5
Absolute
Growth Rate
(Tests/year)
(thousands)
20.3
85.2
139.3
98. 1
83.8
126.7
89.5
Year
1969-70
1970-71
1971-72
1972-73
1973-74
1974-75
1975-76
1976-77
1977-78
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FI GURE 3.2
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TABLE 3.2
GROWTH IN TOTAL
Total
Admissions
1969-70
1970-71
1971-72
1972-73
1973-74
1974-75
1975-76
1976-77
1977-78
10,671
11,089
11,608
11,459
12,295
13,426
14,012
13,164
13,366
CHEMISTRY TESTS PER
Tests/
Admission
25.2
24.7
26.7
38.5
47.8
47.7
54.0
67.6
69.9
ADMISSION OR
Total
Patient
Days
117,280
114,041
112,941
121,828
132,839
135,786
147,184
142,879
140,952
PATIENT DAY
Tests/
Pt. Day
2.30
2.39
2.74
3.63
4.42
4.71
5.14
6.24
6,56
Year
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occupancy has had some effect on total tests ordered, but
that other factors are of greater importance. However,
interpretation of these results must be made cautiously be-
cause, as will be shown later in the myocardial infarction
study, the distribution of tests is not uniform over the
length of hospital stay. There is a greater test use immedi-
ately following admission than immediately prior to discharge.
The
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TABLE 3.3
CORRELATION BETWEEN MONTHLY TOTAL TESTS AND PATIENT DAYS
Average Length
of Stay ± 1 s.d.
(days)
Average
Monthly Total Tests
(thousands)
Average Monthly
Patient Days
Correlation
Coefficient
10.71 + 0.28
10.79 + 0.32
10.19 + 0.57
63.1 12.1
Year
1973
1974
1975
36.8
49.3
51.1
10.3
11.1
11.5
0.553
0.845
-0.435
0.743
- -
1976 10.74 ± 0.27
- 43
FIGURE 3.3
Monthly Total Chemistries
and Occupancy (Patient Days)
12
MONTHLY
PATI ENT
DAYS
(000's)
-, ,
7U
60
MONTHLY
TOTAL
LAB TESTS
(000's) 50
40
30
MONTH: 3s
YEAR: 1973
* All data points are 3-month
moving averages.
-IV
9
InLVUV
I I I
1974 1975 1976
I I I
I
• 
Aý j
r-
)-
E
E
E-
- 44-
TABLE 3.4
AVERAGE LENGTH OF STAY IN THE HOSPITAL UNDER STUDY
Month Year 1973 1974 1975 1976
Jan 11.50 11.13 10.52
Feb 11.07 10.89 10.63 10.4
Mar 10.57 10.72 10.48 10.68
Apr 10.39 11.08
May 10.47 10.63
June 10.42 10.55
July 11.00 10.63
Aug 10.68 10.72
9.92
9.60
9.30
9.57
9.8
10.5
10.46
10.77
10.79
10.8
Sept 10.53 10.98 10.18 10.9
Oct 10.66 10.55 10.5 11.4
Nov 11.24 10.95 10.2 10.9
Dec 10.75 10.22 10.9 10.8
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patient days
with the tot
of ho
al tes
spital occupancy which correlates
ts performed (thick arrow). Also,
negatively
in 1975,
the average length of stay of a patient in the hospital is
significantly lower than in 1974 or 1976 (Tables 3.3 and 3.4).
It is concluded that there was a short-term change in hospital
utilization during this period, particularly from April to
August, 1975; associated with the admission of a group of
patients with reduced length of hospitalization.
3.2 Distribution of Tests
The frequency of use of 23 major tests over the period
1972 to 1978 is shown in Table 3.5. Here, tests have been
grouped according to the technology used in 1978. In each
year, these tests account for over 90% of the tests performed.
The percentage fraction of total tests not included in this
set of 23 tests shows some variation from year to year, but
there is no clear growth trend. While the introduction of
new tests undoubtedly contributes to the total test volume,
it is not a significant factor in the increase in chemistry
laboratory utilization.
The so-called "LBC"* group of tests (Na, K, Cl, C0 2,
BUN, Creatinine) represents slightly over half of the total tests
performed. This fraction has been remarkably constant from
1971 onwards, as shown in Table 3.6. The growth in LBCs
parallels the growth in total tests performed; see Figure
3.1 Growth in LBCs during the period 1972-74 is greater
*LBC is an acronym standing for 'Lectrolytes, BUN, Creatinine
0 0
TABLE 3.5
TESTS 1972 1973 1974 1975 1976 1977 1978
TOTAL 309.5 442.8 590.2 639.8 755.7 892.3 934.8
SMA6-1* 166.0 236.7 337.7 370.6 437.3 506.3 524.8
Enzymes 38.2 49.6 59.8 67.0 75.0 91.4 94.8
SMA6-11 +  40.4 55.59 66.5 75.9 81.5 94.5 95.0
Glucose 21.4 29.2 34.8 36.3 45.3 47.8 49.0
Alkaline 8.6 10.9 13.4 15.9 16.6 21.3 20.8
Phosphatase
Blood Gases 8.1 16.6 23.9 26.3 35.6 43.01 44.6
Cholesterol 3.4 4.0 5.4 5.9 5.9 7.52 8.4
Amylase 3.0 4.79 5.94 7.3 8.1 12.5 14.0
Subtotal 289.2 407.4 547.5 605.2 705.3 824.3 851.0
% of Total Tests 6.6 8.0 7.2 5.4 6.7 7.6 9.0
Unaccounted
+SMA6-11: Ca,P04,Total Protein,Albumin,Bilirubin,Uric Acid*SMA6-1: Na,K,C1,CO2,BUN,Creatinine
0 0
TABLE 3.6
GROWTH IN LBC AND ENZYMES
% INCREMENT
OVER PRIOR YEAR LBC/TOTAL
.52
.53
.57
.58
.58
.57
.56
TOTAL % INCREMENT
ENZYMES OVER PRIOR YEAR
38,190
49,640
59,830
65,980
74,960
91,380
94,770
YEAR TOTAL
"LBC"
1971-72
1972-73
1973-74
1974-75
1975-76
1976-77
1977-78
ENZYMES
TOTAL
166,030
236,700
337,690
370,600
437,330
506,310
524,880
.12
.12
.10
.11
.10
.10
.10
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3.3 Chemistry Test Costs
The relative direct cost of the increased test volumes
was determined for each year of the study; the data are
summarized in Table 3.7.
From 1972 to the present, there has been an
in the productivity of the technical staff of the
laboratory. Total tests/full time equivalent empl
(FTE) increased from 12.1 in 1972 to 20.7 in 1978,
increase
chemistry
oyees
an increase
ible tha
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include
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TABLE 3.7
RELATIONSHIP OF CHANGES IN TOTAL CHEMISTRY TESTING TO STAFF AND COST DATA
STAFF COSTS
Non-
Payroll Payroll
$ x 103 $ x 103
196
263
322
404
540
664
746
69
108
129
152
240
324
370
Ratio
Total Tests
Total Costs
1.21
1.19
1.30
1.11
0.97
0.90
0.84
*FTE = Full Time Equivalent Employees
Year
1972
1973
1974
1975
1976
1977
1978
Total
Tests
x 103
320
443
588
615
756
892
935
FTE*
26.5
27.5
33.2
34.2
39.0
44.4
45.4
Tests/FTE
12.08
16.11
17.71
17.98
19.38
20.09
20.69
Rat io
Cost ($)
Tests
.83
.84
.77
.90
1.03
1.11
1.19
0 0 0 ·
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Chapter 4. MYOCARDIAL INFARCTION STUDY
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influences observed with the LBC or in the hospital
population at large. This is an intriguing observation,
and might provide some insight into the causes of the
increased laboratory utilization, since, in this group
of patients, the enzymes are used for diagnostic pur-
poses (in contrast to the monitoring functions of the
LBC determinations - see below).
In the period before the application of serum iso-
enzyme techniques in 1977 (which permit the differenti-
ation of isoenzyme patterns of serum enzymes that are
characteristic of different diseases and which might
cause elevations in their overall levels), multiple
and serial enzyme determinations were required to
clearly establish the characteristic sequential pattern
of serum enzyme increase and decline associated with
acute myocardial infarction. Thus, the pattern and
frequency of serum enzyme analysis was not as susceptible
to variation as were other varieties of tests, particu-
larly the "LBCs".
4.2 Intervals Between Tests
Ordering patterns of clinical tests have undergone
significant changes during the period of study. A major
- 58 -
change is an increase in the frequency of testing resulting
in progressively shorter intervals between consecutive tests.
This shift is evident from Figure 4.4 which shows the frequen-
cy of various intervals between consecutive tests, for electro-
lytes, BUN and creatinine determinations. Although the most
frequent intervals between tests in 1963 is one day, very sig-
nificant numbers of tests were ordered at longer intervals,
some with intervals greater than 6 days. As a consequence the
average interval between tests in 1963 was 4.2 days. The in-
tervals between consecutive tests fell progressively during
the subsequent periods of study, with increasingly frequent
requests for daily determinations. By 1978,
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TABLE 4. 1
WEIGHTED INTERVALS BETWEEN TESTS
"LBC"
(Electrolytes, BUN, Creatinine)
Intervals (Days)
.87
1.6
1.7
2.9
2.9
4.2
Serum Enzymes
Intervals (Days)
1.1
N.D.
1.5
N.D.
2.0
1.7
Year
1978
1975
1973
1970
1968
1963
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daily testing was observed in 1963 (admittedly less frequen-
tly than in 1973). Thus although the laboratory could respond
to this intensity of demand in 1963, these daily requests were
significantly less common before 1973.
4.3 Frequency of Abnormal Tests
The percent of total number of tests that were found to
be abnormal was determined at each of the intervals studied
(Table 4.2). With respect to the serum electrolytes, BUN and
creatinine, there was a generally progressive reduction in the
percent of abnormal tests between 1963 and 1977. Comparable
changes were not observed for the serum enzyme determinations,
since myocardial infarction results in predictable patterns
of serum enzyme abnormalities and is consequently not as open
to such fluctuation.
4.4 Test-Ordering Patterns (Grouping)
4.4.1-Frequency of test combinations: With the development of
multichannel instruments such as the Technicon SMA-6, which
could provide simultaneous determinations of multiple differ-
ent laboratory tests from a given sample, the question arises
whether such instruments stimulate the physicians to request
groups of tests (according to their availability from these
instruments) rather than individual tests (as was common for-
merly). We approached this question by examining the fre-
quency with which the combinations of the 6 "LBC" tests (com-
bined in the SMA 4+2) had been ordered simultaneously, during
- 63 -
TABLE 4.2
Percent Abnormal Tests - Electrolytes, BUN, Creatinine
1963 1968 1970 1973 1975
48 37 39 34 24 28
Yea r 1977
% Abnormal
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This clearly indicates that, in this sample, the prac-
tice of ordering the combination of six tests ("LBC") ante-
dated the availability of the multichannel SMA 4+2. The deci-
sion to offer a combination of these 6 tests seems to reflect
an attempt by the instrument manufacturers to be responsive
to a pre-existent propensity to order a combination of these
tests. While the availability of this combination in a single
instrument may have encouraged the ordering of tests in com-
bination, the instrumentation did not initiate the trend, in
this instance.
4.5 Comparison of the Frequency of Diagnostic and Monitoring
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TABLE 4.3
AVERAGE NUMBER OF TESTS
FOR FIRST AND LAST FIVE DAYS OF HOSPITAL STAY PER PATIENT
Avg.# Tests
per day per
patient
Year
1963 67 68 70 73 75 77 78
5 days after 3.8 4.7 6.2 6.9 9.7 11.0 14.9 21.8
admission
5 days prior 0.25 0.8 0.29 0.49 1.2 1.4 4.1 5.3to discharge
First 5 days
Last 5 days 15.1 5.8 21.3 14.1 7.8 7.9 3.6 4.1
five days of hospitalization
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This also indicates that early progressively higher
of sustained monitoring activity is also evident in
recent groups (in 1973 and particularly in 1978).
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(the elderly and the poor) who might be expected to have more
serious health problems, these have affected the case-mix of
the hospitals in an adverse way.
In order to avoid these sources of variability, we have
also elected to study the lab utilization in a well-defined,
though small, group of patients. They were selected as having
uncomplicated myocardial infarction, and are as close to a
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5.2.3 Physician-Related Factors
Specialization: The physician-related factors seem to
play the predominant role in the remarkable increase in lab-
oratory utilization. The effect of a high degree of sub-
specialization has already been discussed. In the particular
hospital used in the study, the degree of subspecialization
is rather extreme, with a high degree of subspecialization in
internal medicine, pediatrics and surgery and very few general
has a
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internists, pediatricians or surgeons on the staff. The staff
is essentially full-time (and until recently were salaried
employees of the hospital); all have teaching appointments at
the medical school, and many are actively engaged in clinical
research.
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testing.
Lack of effective interaction/consultation with lab-
oratories: There is no formal interaction/consultation
between clinical laboratory directors and the clinicians/
house officers who utilize the laboratory data. No attempts
have been made to intervene or otherwise influence the order-
ing of laboratory tests by clinicians/house officers (other
than attempts to discourage unnecessary "stat" [urgent]
requests for exceptionally rapid reporting of results). On
the contrary, the laboratory has attempted to respond to the
increased demands with increased services, automation, and
more extensive coverage to almost 24 hour service, seven days
a week.
Malpractice: Another general physician related factor
is the increasing threat of malpractice suits, resulting in
an increase in "defensive medicine", a term applied to the use
of diagnostic procedures to avoid litigation. Physicians have
felt compelled, in some instances, to carry out laboratory
testing in cases in which the physical examination and history
have already yielded an unquestionable diagnosis. The major
increase in rates began in 1972 and may have contributed to
the increased laboratory utilization evident at that time.
Influence of technology: A much more significiant
factor relates to the attitide toward technology shared by
physician and patient alike. (For a comprehensive discussion
of this point, see Reiser's
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5.3 Determination of Appropriate Levels of Laboratory
Utilization
As is evident from the foregoing discussion, there are
a great many causes of increased laboratory utilization over
the past 30-40 years. We have, thus far, avoided the issue of
whether this remarkable growth in utilization is necessarily
indicative of unneccessary and inappropriate usage and should
be vigorously discouraged. While most people will agree that
some of this growth is unnecessary, there may be significant
differences of opinion on how much of it would fit into that
category. Short of a case-by-case review of hospital records,
how can the question of the appropriateness of laboratory
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sh some level of current practice as
rrect standard. This has the advantage of relative sim-
ity, but it does not resolve the difficulty of establish-
that the "normal" behavior is actually appropriate.
This brief discussion of the problem of establishing an
uivocal method of establishing the "proper" level of
ratory utilization, for different categories of diseases
patients indicates the problems inherent in any sample
toring schemes (such as determining percent abnormal, or
frequency).
General Recommendations
The best alternative suggested by a number of authors
9,23,28) involves a controllin
oratory directors and clinicians i
ing of laboratory usage. Educatio
the appropriate use of particular
normal values and relation of test
as the costs of laboratory tests;
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~I
(29).programs
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Key individuals in the implementation are the directors of the
clinical laboratories, who would need to play an expanded role
as laboratory consultant, advising on the use and interpreta-
tion of laboratory tests, design diagnostic test strategies
for different types of disease, and establish a test monitor-
ing system to provide continuing review of current laboratory
utilization.
The fundamental problem of the consequences of increased
dependence of the clinician upon diagnostic technology still
remains unresolved. Its use can enlarge the physicians'
knowledge of disease, but they may rely too much on such tech-
nology, and not enough on diagnostic capability based upon
their own ability and experience. Otherwise the physician
"risks becoming merely an intermediary between the patient
and the medical judgments rendered by technical experts and
machines" (4).
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